The Effect of Biologic Disease-Modifying Antirheumatic Drugs in Targeting Disease Remission in Axial Spondyloarthritis: A Systematic Literature Review

被引：0
|
作者：
Machado, Ana Rita [1 ,2 ]
Manica, Santiago Rodrigues [3 ,4 ]
Silva, Joana Leite [5 ]
Pimentel-Santos, Fernando [3 ,4 ]
Costa, Jose Tavares [5 ]
Vieira-Sousa, Elsa [1 ,2 ]
机构：
[1] Univ Lisbon, Ctr Acad Med Lisboa, Fac Med, Unidade Invest Reumatol,Inst Med Mol, Lisbon, Portugal
[2] Ctr Hosp Lisboa Norte, Hosp Santa Maria, Serv Reumatol & Doencas Osseas Metab, Lisbon, Portugal
[3] Ctr Hosp Lisboa Ocidental, EPE, Hosp Egas Moniz, Rheumatol, Lisbon, Portugal
[4] NOVA Med Sch, CEDOC, Lisbon, Portugal
[5] Unidade Local Saude Alto Minho, Rheumatol, Ponte do Lima, Portugal
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2573
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Disease-modifying antirheumatic drugs
    Slack, S
    Furst, DE
    DRUGS OF TODAY, 1996, 32 (06) : 463 - 476
  • [22] DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    SMITH, MD
    AHERN, MJ
    MEDICAL JOURNAL OF AUSTRALIA, 1992, 157 (11-12) : 797 - 801
  • [23] SYSTEMIC TREATMENT FOR ACUTE ANTERIOR UVEITIS (SYNTHETIC AND BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS): A SYSTEMATIC REVIEW
    Gomez-Gomez, A.
    Loza, E.
    Rosario, M. P.
    Carmona, L.
    Espinosa, G.
    Garcia Ruiz de Morales, J. M.
    Herrera, J. M.
    Munoz-Fernandez, S.
    Cordero, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 414 - 415
  • [24] To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question
    Lukasik, Zuzanna
    Carron, Philippe
    Webers, Casper
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2023, 37 (03):
  • [25] Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis
    Kemper, Alex R.
    Van Mater, Heather A.
    Coeytaux, Remy R.
    Williams, John W., Jr.
    Sanders, Gillian D.
    BMC PEDIATRICS, 2012, 12
  • [26] Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis
    Alex R Kemper
    Heather A Van Mater
    Remy R Coeytaux
    John W Williams
    Gillian D Sanders
    BMC Pediatrics, 12
  • [27] Risk of cutaneous herpes zoster in patients with spondyloarthritis treated with conventional and biologic disease-modifying antirheumatic drugs
    Wong, Sabrina Ching Tung
    Li, Iris Wai Sum
    Ng, Alexandra Hoi Yan
    Lau, Chak Sing
    Chung, Ho Yin
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (02) : 189 - 196
  • [28] Sex Differences in Time to Initiate Nonsteroidal Anti-Inflammatory Drugs or Biologic Disease-Modifying Antirheumatic Drugs Among Patients With Axial Spondyloarthritis
    Shridharmurthy, Divya
    Lapane, Kate L.
    Baek, Jonggyu
    Nunes, Anthony P.
    Weisman, Michael H.
    Kay, Jonathan
    Liu, Shao-Hsien
    ARTHRITIS CARE & RESEARCH, 2024, 76 (08) : 1149 - 1161
  • [29] A clinical and economic review of disease-modifying antirheumatic drugs
    Gabriel, SE
    Coyle, D
    Moreland, LW
    PHARMACOECONOMICS, 2001, 19 (07) : 715 - 728
  • [30] A Clinical and Economic Review of Disease-Modifying Antirheumatic Drugs
    Sherine E. Gabriel
    Douglas Coyle
    Larry W. Moreland
    PharmacoEconomics, 2001, 19 : 715 - 728
12345